Only a minority of cancer cells affect the growth and metastasis of tumors

February 2, 2016
Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute

New research shows that a small minority of cancer cells in neuroendocrine tumours of the pancreas contribute to the overall growth and metastasis of the tumour. This discovery was made by a research group at Lund University, in collaboration with researchers at Karolinska Institutet, in Sweden.

The findings are of fundamental biological importance for the understanding of the different functions of cancer cells, and are now published in the scientific journal PNAS.

Cancer emerges when mutations and other shut down the control system for growth that can normally be found in our cells. All cancer cells in a tumour were previously believed to have the same potential to grow and metastasise, but recent studies show that tumours are comprised of several types of cancer cells with different genetic alterations.

"The fact that there are so many different types of cells within a single tumour could explain why only some cancer cells are able to metastasise, and why some patients experience recurrence of their tumorous disease, despite having undergone extensive treatment", explains Professor Kristian Pietras at the Department of Laboratory Medicine at Lund University.

Neuroendocrine tumours, NET, is a generic name for a type of hormone-producing tumour. In their study, the research group showed that in neuroendocrine tumours of the pancreas, a small minority of significantly contributed to the overall growth of the tumour.

"These tumour cells represent less than one per cent of all the cells in the tumour, yet they essentially control the tumour's ability to grow and metastasise", says Eliane Cortez, doctoral student at the Department of Laboratory Medicine, Lund University, and lead author of the study.

A type of protein (PDGFD) is secreted from the blood vessels of the tumour, and sends signals to a receptor (PDGFRβ) located on the surface of a small percentage of cancer cells. In turn, this minority of cancer cells secrete growth factors to other cells in the tumour, resulting in the growth of the entire tumour. Through animal testing using mice, the researchers disabled the PDGFD, which made the overall growth of the tumour dramatically decline, even though the measure only had a direct impact on a very small percentage of the tumour cells. PDGFD signalling through PDGFRβ has been previously described in other tissues and tumours, but never in this type of cancer.

"It was also very interesting for us to find that early metastases almost exclusively contained cancer cells with PDGFRβ on the surface, suggesting that this cell has an important function when it comes to preparing and promoting the metastasis of cancer cells to other organs", explains Eliane Cortez.

The discovery is of fundamental biological importance because it increases the understanding of how a tumour consists of different types of cancer cells with different functions. To understand the level of aggression of a tumour, it is important to accurately describe its structure, as also smaller populations of cancer cells may have a major impact on the 's overall growth.

"We have studied the occurrence of these -controlling in humans as well, but the next step is to more systematically and in larger studies examine the cells and see how they respond to treatment", says Kristian Pietras.

Explore further: Protein research uncovers potential new diagnosis and therapy for breast cancer

More information: Eliane Cortez et al. Functional malignant cell heterogeneity in pancreatic neuroendocrine tumors revealed by targeting of PDGF-DD, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1509384113

Related Stories

Protein research uncovers potential new diagnosis and therapy for breast cancer

October 8, 2015
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now's Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects ...

Blood vessel cells help tumours evade the immune system

August 24, 2015
A study by researchers at Sweden's Karolinska Institutet is the first to suggest that cells in the tumour blood vessels contribute to a local environment that protects the cancer cells from tumour-killing immune cells. The ...

Cooperation between cancer cells makes therapies ineffective, suggests new treatment

January 26, 2015
Cooperation between cancer cells makes current therapies ineffective but also suggests new treatment

Cancer's growth driven by minority of cells within a tumour

July 31, 2014
US cancer researchers have unearthed further evidence that a tumour's growth can be fuelled by just a small minority of its cells.

Cancer cells take up nanoparticles more rapidly than normal brain cells

December 17, 2015
New research carried out by drug delivery experts at The University of Nottingham has highlighted more advantages to using nanoparticles for the delivery of cancer drugs.

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.